We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.83%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
+$2.18B
Cap. Flow
+$425M
Cap. Flow %
0.92%
Top 10 Hldgs %
15.17%
Holding
2,954
New
28
Increased
2,252
Reduced
604
Closed
50

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$128M
2
BKR icon
Baker Hughes
BKR
+$26.7M
3
IQV icon
IQVIA
IQV
+$14.5M
4
OKE icon
Oneok
OKE
+$14.3M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$11.2M

Sector Composition

Rank Sector Weight
1 Financials 16.64%
2 Technology 15.8%
3 Healthcare 13.57%
4 Industrials 10.87%
5 Consumer Discretionary 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KO icon
26
Coca-Cola
KO
$354B
$300M 0.65%
6,663,194
+54,678
+0.8% +$2.49M
PEP icon
27
PepsiCo
PEP
$186B
$282M 0.61%
2,527,380
-15,621
-0.6% -$1.8M
MRK icon
28
Merck
MRK
$324B
$281M 0.61%
4,605,539
-73,149
-2% -$4.43M
DD icon
29
DuPont de Nemours
DD
$18.6B
$274M 0.6%
1,561,071
+768,526
+97% +$128M
PM icon
30
Philip Morris
PM
$301B
$270M 0.59%
2,427,769
+19,820
+0.8% +$2.31M
DIS icon
31
Walt Disney
DIS
$165B
$269M 0.59%
2,730,228
+89,081
+3% +$9.16M
ORCL icon
32
Oracle
ORCL
$331B
$260M 0.56%
5,368,060
+19,989
+0.4% +$995K
AMGN icon
33
Amgen
AMGN
$203B
$254M 0.55%
1,364,234
+19,003
+1% +$3.37M
MMM icon
34
3M
MMM
$89B
$236M 0.51%
1,344,939
+11,502
+0.9% +$1.99M
MCD icon
35
McDonald's
MCD
$188B
$231M 0.5%
1,471,838
+28,426
+2% +$4.46M
MA icon
36
Mastercard
MA
$477B
$230M 0.5%
1,626,616
+12,878
+0.8% +$1.7M
BA icon
37
Boeing
BA
$165B
$229M 0.5%
899,054
+2,282
+0.3% +$532K
IBM icon
38
IBM
IBM
$202B
$223M 0.48%
1,606,003
+37,450
+2% +$5.22M
ABBV icon
39
AbbVie
ABBV
$458B
$217M 0.47%
2,444,635
-14,766
-0.6% -$1.12M
WMT icon
40
Walmart Inc
WMT
$871B
$205M 0.45%
7,873,956
-71,397
-0.9% -$1.87M
CELG
41
DELISTED
Celgene Corp
CELG
$193M 0.42%
1,324,704
+12,344
+0.9% +$1.68M
GILD icon
42
Gilead Sciences
GILD
$161B
$188M 0.41%
2,319,884
-8,861
-0.4% -$678K
MDT icon
43
Medtronic
MDT
$107B
$188M 0.41%
2,416,107
+55,903
+2% +$4.64M
MO icon
44
Altria Group
MO
$122B
$185M 0.4%
2,915,635
+45,317
+2% +$3.02M
HON icon
45
Honeywell
HON
$77.1B
$183M 0.4%
1,432,856
+47,223
+3% +$5.86M
NVDA icon
46
NVIDIA
NVDA
$5.01T
$181M 0.39%
40,577,880
+1,951,520
+5% +$8.11M
SLB icon
47
SLB Ltd
SLB
$77.8B
$169M 0.37%
2,428,235
+67,265
+3% +$4.45M
BMY icon
48
Bristol-Myers Squibb
BMY
$127B
$167M 0.36%
2,618,181
+20,935
+0.8% +$1.22M
UNP icon
49
Union Pacific
UNP
$183B
$163M 0.35%
1,404,955
+13,048
+0.9% +$1.4M
ABT icon
50
Abbott
ABT
$180B
$162M 0.35%
3,042,445
+30,654
+1% +$1.54M

Similar funds

RhumbLine Advisers's Q3 2017 Portfolio in Review

As of Q3 2017, RhumbLine Advisers held 2,954 positions worth $46B, up 5% from $43.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 2.6%. RhumbLine Advisers opened 28 new positions and exited 50, leaving the 2,954-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q3 2017 buy was Baker Hughes: 750,985 shares worth $27.5M.
  • RhumbLine Advisers added most to DuPont de Nemours in Q3 2017, an estimated $128M increase.
  • RhumbLine Advisers's biggest Q3 2017 reduction was UnitedHealth, cutting an estimated $22.8M.
  • RhumbLine Advisers fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $114M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $46B portfolio in Q3 2017.
  • RhumbLine Advisers opened 28 new positions and closed 50 in Q3 2017.
  • RhumbLine Advisers's portfolio value rose 5% quarter-over-quarter to $46B.

Based on RhumbLine Advisers's 13F filing for Q3 2017, filed 6 Nov 2017.